We are live on ! Find out more
DGX icon

Quest Diagnostics

852 hedge funds and large institutions have $15.2B invested in Quest Diagnostics in 2024 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 295 increasing their positions, 310 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 73

10% more call options, than puts

Call options by funds: $62.2M | Put options by funds: $56.4M

1% more funds holding

Funds holding: 841 → 852 (+11)

7% more capital inflows, than outflows

Capital inflows: $1.26B | Capital outflows: $1.18B

0.14% more ownership

Funds ownership: 87.72% → 87.86% (+0.14%)

5% less repeat investments, than reductions

Existing positions increased: 295 | Existing positions reduced: 310

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
852
Holders Change
+11
Holders Change %
+1.31%
% of All Funds
12.19%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
94
Increased
295
Reduced
310
Closed
73
Calls
$62.2M
Puts
$56.4M
Net Calls
+$5.84M
Net Calls Change
-$46.4M

DGX Hedge Fund Activity: Q3 2024 in Review

852 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2024, worth a combined $15.2B — up 14% from $13.3B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new DGX positions and 73 closed out — a net gain of 21 holders — while 295 added to existing stakes and 310 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $552M. The largest seller was Millennium Management, cutting an estimated $117M.

  • 852 institutional investors held Quest Diagnostics (DGX) as of Q3 2024, up from 841 in Q2 2024.
  • Funds reported $15.2B of Quest Diagnostics stock for Q3 2024, up 14% quarter-over-quarter.
  • 94 funds opened new Quest Diagnostics positions in Q3 2024 and 73 closed out, a net change of +21 holders.
  • The largest Quest Diagnostics buyer in Q3 2024 was T. Rowe Price Associates, an estimated $552M added.
  • The largest Quest Diagnostics seller in Q3 2024 was Millennium Management, an estimated $117M sold.

Based on aggregated 13F filings for Q3 2024.